Systematic review of haemorrhage and rupture of hepatocellular adenomas

British Journal of Surgery

Volumn 99, Issue 7, 2012, Pages 911-916

  Van Aalten, S M ^a   De Man, R A ^a   Ijzermans, J N M ^a   Terkivatan, T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862756666     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8762     Document Type: Review

References (40)

1. van der Sluis FJ, Bosch JL, Terkivatan T, de Man RA, Ijzermans JN, Hunink MG. Hepatocellular adenoma: cost-effectiveness of different treatment strategies. Radiology 2009; 252: 737-746.
2. Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187: 181-191. (Pubitemid 38183430)
3. Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 2008; 15: 2795-2803.
4. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-1705.
5. Terkivatan T, deWilt JH, de Man RA, van Rijn RR, Tilanus HW, IJzermans JN. Treatment of ruptured hepatocellular adenoma. Br J Surg 2001; 88: 207-209. (Pubitemid 32142706)
6. van derWindt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA et al. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006; 93: 1495-1502. (Pubitemid 44893651)
7. Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12: 509-522.
8. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242: 644-648. (Pubitemid 9252465)
9. Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 1996; 62: 825-829. (Pubitemid 26322039)
10. Barrows GH, ChristophersonWM. Human liver tumors in relation to steroidal usage. Environ Health Perspect 1983; 50: 201-208. (Pubitemid 13040443)
11. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50: 481-489.
12. Chaib E, Gama-Rodrigues J, Ribeiro MA Jr., Herman P, Saad WA. Hepatic adenoma. Timing for surgery. Hepatogastroenterology 2007; 54: 1382-1387. (Pubitemid 47203431)
13. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 1995; 165: 303-308.
14. Closset J, Veys I, Peny MO, Braude P, Van Gansbeke D, Lambilliotte JP et al. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 2000; 47: 1382-1384.
15. Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009; 16: 640-648.
16. Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976; 294: 470-472.
17. Gonzalez F, Marks C. Hepatic tumors and oral contraceptives: surgical management. J Surg Oncol 1985; 29: 193-197. (Pubitemid 15069855)
18. Hung CH, Changchien CS, Lu SN, Eng HL, Wang JH, Lee CM et al. Sonographic features of hepatic adenomas with pathologic correlation. Abdom Imaging 2001; 26: 500-506.
19. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000; 214: 861-868. (Pubitemid 30115393)
20. Ji Y, Zhu X, Sun H, Tan Y, Ma Z, Ye Q et al. Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation. Chin Med J (Engl) 2000; 113: 852-857.
21. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988; 208: 558-564. (Pubitemid 18267695)
22. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 1986; 160: 53-58. (Pubitemid 16090073)
23. Mathieu D, Paret M, Mahfouz AE, Caseiro-Alves F, Tran Van Nhieu J, Anglade MC et al. Hyperintense benign liver lesions on spin-echo T1-weighted MR images: pathologic correlations. Abdom Imaging 1997; 22: 410-417. (Pubitemid 27272821)
24. Nime F, Pickren JW, Vana J, Aronoff BL, Baker HW, Murphy GP. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer 1979; 44: 1481-1489. (Pubitemid 10193397)
25. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 1994; 163: 113-116. (Pubitemid 24225698)
26. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001; 67: 173-178. (Pubitemid 33738212)
27. Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 1998; 4: 388-398. (Pubitemid 28413240)
28. Thompson HH, Tompkins RK, LongmireWP Jr. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197: 375-388. (Pubitemid 13112776)
29. Toso C, Majno P, Andres A, Rubbia-Brandt L, Berney T, Buhler L et al. Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol 2005; 11: 5691-5695. (Pubitemid 41684926)
30. Vana J, Murphy GP, Aronoff BL, Baker HW. Survey of primary liver tumors and oral contraceptive use. J Toxicol Environ Health 1979; 5: 255-273. (Pubitemid 9214755)
31. Weimann A, Ringe B, Klempnauer J, Kockerling F, Fronhoff K, Ott R et al. Critical issues in the diagnosis and treatment of hepatocellular adenoma. HPB 2000; 2: 25-32. (Pubitemid 30335769)
32. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001; 21: 877-892.
33. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005; 236: 166-177. (Pubitemid 40853309)
34. Hussain SM, van den Bos IC, Dwarkasing RS, Kuiper JW, den Hollander J. Hepatocellular adenoma: findings at state-of-The-Art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006; 16: 1873-1886. (Pubitemid 44193172)
35. Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926-929.
36. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci 2006; 1089: 228-236. (Pubitemid 47092098)
37. Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y et al. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33: 1202-1208. (Pubitemid 34517036)
38. Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Dig Surg 2010; 27: 56-60.
39. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg 2010; 27: 39-45.
40. van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol 2011; 55: 120-125.